>. Requests should be made three days in advance of the event when possible.
March 28 -
CANCELED: Solar Winds and Magic Bullets: Making Our Way in a World of Radiation
RESCHEDULED TO JUNE 6
April 4 -
How is the Brain Organized and How Does it Work?
Dear Colleagues,
The next Demystifying Medicine lecture concerning how the brain works is Tuesday, April 4, at 4:00 p.m. ET. The speaker are Nelson Spruston, P.hD., (Janelia HHMI) and Marcus Raichle, M.D., (Washington University).
This is a remote-only event. Watch at https://videocast.nih.gov/watch=48833.
For centuries, the brain was inaccessible for structural and functional studies. The advent of in vivo imaging technologies coupled with advances in neurobiology have made neuroscience an exciting field. Our next Demystifying Medicine speakers are at the forefront of in vivo and in vitro studies of complex brain structure and function. Join us in this exciting adventure into the challenging "brave new world"!
Marcus E. Raichle, M.D., is the Wolff Distinguished Professor of Medicine and Senior Investigator in the Neuroimaging Labs Research Center of the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St Louis. Previously the director of the Neuroimaging Research Center, Raichle is a trailblazer in the study of human brain function through development and use of positron emission tomography (PET) and functional magnetic resonance imaging (fMRI). His landmark studies described the first integrated strategy for the design, execution and interpretation of functional brain images.
In other seminal studies, Raichle and colleagues developed the concept of a default mode of brain function and invigorated studies of intrinsic functional activity, an issue largely dormant for more than a century. An important facet of this work was discovery of a unique fronto-parietal network in the brain known as the default network which is now a worldwide focus in studies of brain function in health and disease.
Nelson Spruston, Ph.D. is chief of scientific operations and Senior Investigator at Howard Hughes Medical Institute's Janelia Research Campus. His research focus is on hippocampal diversity and the complexity of cells and synapses which contribute to memory-guided behavior, such as spatial navigation and emotional responses. Spruston and his team use imaging methods, next-generation RNA sequencing, in vitro and in vivo electrophysiology, and behavior to study the diversity of cell types in the mouse hippocampus. His research is critical for understanding how memories are stored and recalled, as well as diseases that affect these processes.
Please join us as we learn more about the most complex part of the human body. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48833.
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?SUBED1=DEMYSTIFYINGMED&A=1.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH. See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
April 11 -
Psychobiology: Mushrooms...Others
Dear Colleagues,
The next Demystifying Medicine lecture will focus on Psychobiology: Mushrooms...And Others, on Tuesday, April 11, at 4:00 p.m. ET with Frederick Barrett, PhD (Johns Hopkins University) and David Olson, PhD (University of California, Davis). This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48835 .
There are many types of hallucinations and many causes. Among known causes are psycho-active mushrooms (Magic Mushroom) and LSD. This session will present exciting developments which address: How are hallucinations produced? Can administration of hallucinogenic compounds be therapeutically helpful in neuropsychiatric and other diseases? Are the putative therapeutic effects due to specific neural pathways? Can these effects be separated from hallucinations? Is this a "brave new world" for therapy and neuroscience?
Frederick Barrett, PhD, Associate Professor of Psychiatry and Behavioral Sciences, Johns Hopkins University's Center for Psychedelic and Consciousness Research explores the neural basis of emotion and altered states of consciousness relating to music, pharmacological interventions, behavioral measures, computerized testing, and brain imaging techniques. His research includes acute and long-term effects of psychedelic experiences on emotions, cognition, and the brain. Psychedelic drugs, such as psilocybin and LSD, disrupt brain networks for cognitive control and activate brain regions that support emotions and memories, Long-term effects include reduced negative emotions and increased positive emotions, which may explain their therapeutic effects.
David Olson, PhD, Associate Professor, Department of Biochemistry and Molecular Medicine, Department of Chemistry, University of California, Davis uses synthetic chemistry, molecular neurobiology, and behavioral neuropharmacology to understand mechanisms underlying the effects of psychoplastogens on the nervous system. The goal is to develop next generation neurotherapeutics.
Please join us as we learn more about the Psychobiology. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48835
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
April 18 -
Fat: Biology and Staying Thin
Dear Colleagues,
Everyone is concerned about being overweight due to fat accumulation which is a risk factor in cancer, diabetes, immunity, cardiovascular and neurodegenerative diseases and life span. It is mainly a result of high caloric diets, physical inactivity and altered metabolism. How does fat accumulation occur and play a critical role in human health?
The next Demystifying Medicine lecture will focus on Fat: Biology and Staying Thin, on Tuesday, April 18, at 4:00 p.m. ET with Kevin Hall, PhD and Aaron Cypress, MD, PhD, from the NIDDK/NIH. This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48837 .
Kevin Hall, PhD is the Integrative Physiology Section Chief at NIDDK. His goal is to improve the understanding of body weight regulation and develop practical tools for research and clinical use. Dr. Hall's research concerns how metabolism and the brain adapt to diet and physical activity interventions. Experiments in both humans and rodents are revealing the complex mechanisms regulating macronutrient metabolism, body composition and energy expenditure. His research also involves mathematical models to quantitatively describe and predict experimental results. Dr. Hall has received many awards including NIH Director' NIDDK Director's Award twice; E.V. McCullum Award from the American Society for Nutrition, Lilly Scientific Achievement Award from The Obesity Society, and the Guyton Award for Excellence in Integrative Physiology from the American Society of Physiology. His award-winning Body Weight Planner (http://BWPlanner.niddk.nih.gov) has been used by millions of people to help predict how diet and physical activity dynamically interact to affect human body weight.
Aaron Cypress, MD, PhD, MMSc is Acting Section Chief: Translational Physiology Section, Diabetes, Endocrinology, & Obesity Branch. His research focusses on cell and molecular biology, biochemistry and integrated physiology of white and brown fat, using noninvasive measurement techniques. Clinical trials and basic science are used to understand how brown fat works at the levels of cells and translate the results into practical treatments of obesity, diabetes, and other chronic illnesses.
Please join us as we learn more about why and how are excessive fat bad for your health. Can we really become thin? And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48837
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
April 25 -
Out of Africa: Genomic and Environmental Determinants of Global Health
Dear Colleagues,
The next Demystifying Medicine session, entitled Out of Africa: Genomic and Environmental Determinants of Global Health, will be held on April 25 at 4 p.m. EDT with Charles Rotimi, PhD (NHGRI) and Clement Adebamowo, BM, ChB, ScD, FWACS, FACS (University of Maryland).
This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48839 .
The range of personal, social, economic, and environmental factors that influence health status are known as determinants of health. Some biological and genetic factors affect specific populations more than others. Examples of biological and genetic determinants of health include age, sex, inherited conditions, and genetic make-up.
Charles Rotimi, PhD is an NIH Distinguished Investigator and the Scientific Director of the NHGRI intramural research program. Dr. Rotimi came to the NIH in 2008 to found the trans-institute Center for Research on Genomics and Global Health, with the mission of advancing research into the role of culture, lifestyle, and genomics in disease etiology, health disparities, and variable drug response. His lab develops genetic epidemiology models and conducts epidemiologic studies that explore the patterns and determinants of common complex diseases in human populations with particular emphasis on populations of the African Diaspora. His team published the first genome-wide scan for hypertension in African Americans and for type-2 diabetes in West Africans. His lab contributes to the global understanding of human genetic variation by actively participating in the development of international genomic resources including the HapMap, the 1000 Genomes, and the African Genome Variation Projects.
Clement Adebamowo, BM, ChB, ScD, FWACS, FACS is a tenured Professor of Epidemiology and Public Health and member of the Program in Oncology at the University of Maryland School of Medicine, and Director for Global Health Cancer Research and Associate Director of Diversity, Equity, and Inclusion at the Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine. Dr. Adebamowo conducts population science cancer research focused on using epidemiology, genomics, microbiomics, and metagenomics to understand the role of persistent high-risk HPV infections in development of cervical cancer and discovery of novel biomarkers for cervical cancer screening. In the area of cancer health disparities research, he works with colleagues on developing scientifically accurate messages to optimize recruitment strategies and study procedures in clinic-based settings for increased uptake of HPV vaccines in the West Baltimore community. Dr. Adebamowo and his research team are also using chatbots to provide health education for HPV vaccination among African Americans in Baltimore.
Please join us as we learn more about genomic determinants of global health from these two experts. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48839
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
May 2 -
Cancer: Metastasis and Drivers
The next Demystifying Medicine session, entitled Cancer: Metastasis and Drivers, will be held on May 2 at 4 p.m. EDT with Jonathan Hernandez, MD and Kandace Tanner, PhD from the National Cancer Institute (NCI).
This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48841
Most cancer patients die from metastasis and not their primary tumor. With few exceptions, metastatic disease is incurable. How cancer cells manifest metastatic potential, enter and exit a dormancy stage, develop honing to specific sites and eventually establish metastatic focus are challenging problems for basic science and clinical investigation. The hope for effective therapy lies in understanding these basic processes.
What do we know about these processes and what do we need to know is the topic of the next DM session.
Jonathan Hernandez, MD is a NCI Surgical Oncologist, Head of Metastasis Biology Section, Chief of the Surgical Oncology Section, and an Associate Professor of Surgery at the Uniformed Services University of the Health Sciences. Dr. Hernandez specializes in clinical and basic research of metastasis, particularly involving the liver. His research efforts focus on implementation of ex-vivo human tumor systems that allow his lab to fully characterize tumors from the operating room and evaluate new therapies in an unfettered platform.
Kandace Tanner, PhD is a NCI Senior Investigator in the Laboratory of Cell Biology, and Head, Tissue Morphodynamics Section. Dr. Tanner is a biophysicist who investigates basic mechanisms of metastasis particularly regarding local tissue environment requirements. To fully evaluate the dynamic nature of metastatic disease, Dr. Tanner's group has developed new 3D culture models which incorporate architectural complexity. Using well-defined extracellular matrix ligands to mimic physiological tissue we developed tools that directly quantitate the physical cues that a cell will see in vivo within native tissue, and in the presence of physiologic noise.
Please join us as we learn more about metastatic disease from these two experts. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48841
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
May 9 -
mRNA: Will it Deliver Us from Illness?
The next Demystifying Medicine session on Tuesday, May 9th at 4pm EDT is entitled mRNA: Will it Deliver Us from Illness? The speakers are John Coffin, PhD (Tufts University and NCI) and Paolo Lusso, MD, PhD (NIAID).
This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=49725
mRNA instructs cells in the body to make specific proteins, and proteins play many essential roles in our bodies. mRNA basically uses our own body and biological processes to potentially treat diseases and prevent infections.
Development of mRNA vaccines against several viral disease, most notably COVID-19, has dramatically changed the landscape in vaccinology. Can the same technology be applied for prevention of other infectious diseases...particularly HIV and influenza? Can mRNA methods be useful in treatment of non-infectious diseases? How do some viruses respond to vaccines by producing protective antibodies but the disease progresses without interruption? These and other challenging questions regarding use of mRNA in medicine will be discussed by two global experts in the next Demystifying Medicine session.
John Coffin, PhD is the American Cancer Society Research Professor and Distinguished Professor at Tufts University, and the founding Director of the National Cancer Institute (NCI) HIV Drug Resistance Program, to which he still serves as a consultant. His research areas of interests focus on the interaction of retroviruses' host cells and organisms. His team uses avian and murine viruses to elucidate the nature of the retrovirus-receptor interactions.
Paolo Lusso, MD, PhD is Chief, Viral Pathogenesis Section, in the Laboratory of Immunoregulation. NIAID. Dr. Lusso's research focusses on novel approaches (including mRNA) to the development of an HIV-1 vaccine; structure-function relationships in the HIV-1 envelope; structure-based design of improved therapeutic monoclonal antibodies; molecular basis of HIV-1 immune evasion; and the role of chemokines and other endogenous immune modulators in HIV-1 disease.
Please join us as we learn more from these two experts about how mRNA technology helps treat existing diseases. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=49725
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
May 16 -
Diabetes Mellitus: Great Progress
Diabetes: The Marathon of Life
The next Demystifying Medicine session on Tuesday, May 16th at 4pm EDT is entitled: Diabetes Mellitus: Great Progress - Diabetes: The Marathon of Life
with Douglas Melton, PhD (Harvard University) and Courtney Duckworth, MD (Harvard University - Boston Children's Hospital).
This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48789
Over one hundred years ago, insulin was discovered and quickly proposed to be the "answer" to "cure" for diabetes mellitus. History has not been neither kind nor straightforward. Both "cure" and "treatment" of diabetes remain challenging even as its frequency increases worldwide. Treatment of diabetes by meticulous control of blood glucose levels continues to improve due to different types of insulins, techniques for on-line measurement of glucose levels and insulin administration and greatly improved general medical care to lessen complications related to body weight, infection, exercise, etc. Overcoming insulin resistance in Type 2 diabetes presents additional challenges.
For over 50 years, attempts to replace pancreatic islets or beta cells have not been successful due to immunologic, cell biologic and technical issues. Can these problems be overcome through use of pancreatic stem or iPS generated cells from the individual patient, immunologically matched donor or other novel methodologies?
The May 16th session of Demystifying Medicine addresses these and other questions by presenting astounding progress in the cell biology of diabetes as well as clinical progress in learning how to live with the disease.
Courtney Duckworth, a type 1 diabetic, is a Pediatric resident at Boston Children's Hospital (Harvard) and has contributed greatly to understanding how to live successfully with the disease.
A leading developmental biologist, Dr. Douglas Melton of Vertex Pharmaceutical and formerly Harvard Professor of Developmental Biology and Co-Director of the Stem Cell Biology Program, has made exciting progress in use of beta cell stem cells to treat diabetes.
Please join us as we learn more from these two experts speakers, who are at the forefront of these advances. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48789
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
June 6 -
Solar Winds and Magic Bullets: Making Our Way in a World of Radiation
Dear Colleagues,
The last Demystifying Medicine session of 2023 will occur on Tuesday, June 6th at 4pm EDT and is entitled: Solar Winds and Magic Bullets: Making Our Way in a World of Radiation, with Nicola Fox, PhD (NASA) and Freddy Escorcia, MD, PhD (NCI, NIH).
This is a remote-only event.
Watch at: https://videocast.nih.gov/watch=48831
The topic of this week's Demystifying Medicine session is ionizing radiation. For astronauts traveling beyond the protective electromagnetic fields and atmosphere of the Earth, ionizing radiation is a potentially lethal danger. In the hands of a skilled radiation oncologist, ionizing radiation can save lives. This week's speakers will discuss the latest advances in our knowledge, starting with NASA's missions into the wild blue yonder and then turning to NCI studies in advanced clinical settings.
Nicola Fox, PhD is the associate administrator for NASA's Science Mission Directorate. As NASA's head of science, Fox's portfolio includes more than 100 NASA missions to explore the secrets of the universe. She began her NASA career in 2018 leading the Heliophysics Division, overseeing the agency's efforts to study the Sun and how its constant solar wind affects Earth and other planets. Dr. Fox oversaw NASA's work to study key space phenomena and improve situational awareness of the very space our astronauts, satellites, and robotic missions travel through as they explore the solar system and beyond. Her portfolio also included NASA's robust space weather research to help the U.S. government better predict space weather, which can interfere with radio communications, affect GPS accuracy, and, when extreme, can affect electrical grids on the ground. Prior to that, she worked at the Johns Hopkins University Applied Physics Laboratory, where she was the chief scientist for heliophysics and the project scientist for NASA's Parker Solar Probe.
Freddy Escorcia, MD, PhD is an Investigator and Lasker Clinical Research Scholar within the Molecular Imaging Branch and the Radiation Oncology Branch at NCI's Center for Cancer Research. His research is focused on engineering radioconjugates to yield molecular PET or SPECT imaging agents for hepatocellular carcinoma (HCC), which is critical in early diagnosis and surveillance of this disease and suboptimal with existing conventional methods, especially following local treatments. His research team also focuses on the development of novel imaging agents for HCC, yielding insights that we can use to inform development of therapeutic agents. While their focus is on radiopharmaceuticals, what they learn can be translated to similar technologies including antibody- or peptide-drug conjugates, and have applications beyond HCC as well.
Please join us for our last session of the year, as we learn more from these two expert speakers. And, as always, be prepared to be dazzled and demystified.
Add this to your calendar now with this nifty link, https://videocast.nih.gov/ical.ics?live=48831
ATTENTION TRAINEES: Don't miss a lecture. Join the Demystifying Medicine listserv at https://list.nih.gov/cgi-bin/wa.exe?A0=DEMYSTIFYINGMED.
The Demystifying Medicine course, offered virtually on Tuesdays at 4:00 p.m. ET from January to June this year, bridges developments in medicine with advances in the basic biological and engineering sciences. When possible, a live patient introduces the course topic by discussing their disease, followed by a physician scientist who describes clinical aspects of the disease including therapy and challenges, followed by a bench scientist who describes what we know and don't know regarding mechanism.
Demystifying Medicine is sponsored by the Foundation for Advanced Education in the Sciences (FAES) and the NIH.
See the 2023 course schedule at https://demystifyingmedicine.od.nih.gov. All past Demystifying Medicine lectures are archived at https://videocast.nih.gov/PastEvents?c=45.
Continuing Medical Education (CME) credits are available for this week's lecture and most others in the series.
Sign language interpreting services are available upon request. Individuals who need interpreting services or other reasonable accommodations to participate in this event should contact Kenny Williams, williajk@cc.nih.gov. Requests should be made three days in advance of the event when possible.
For questions about the course, please contact ariasi@mail.nih.gov.
Office of Intramural Research > Office of the Director >
National Institutes of Health >
U.S. Department of Health and Human Services >
HHS Vulnerability Disclosure
This web page was last modified on 5 June 2023.